- Home
- FLO vs OCS Comparison
FLO vs OCS Comparison
Compare FLO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLO | OCS |
|---|---|---|
| Founded | 1919 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | 3 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.4B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLO | OCS |
|---|---|---|
| Price | $8.54 | $27.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $11.20 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 4.3M | 190.5K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $5,256,479,000.00 | N/A |
| Revenue This Year | N/A | $466.06 |
| Revenue Next Year | $0.65 | $479.73 |
| P/E Ratio | $20.66 | ★ N/A |
| Revenue Growth | ★ 3.00 | N/A |
| 52 Week Low | $7.86 | $16.00 |
| 52 Week High | $18.53 | $30.68 |
Technical Indicators
Market Signals| Indicator | FLO | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 57.24 |
| Support Level | N/A | $19.00 |
| Resistance Level | $8.62 | $27.93 |
| Average True Range (ATR) | 0.30 | 1.05 |
| MACD | 0.09 | 0.25 |
| Stochastic Oscillator | 87.58 | 80.53 |
Price Performance
Historical ComparisonAbout FLO Flowers Foods Inc.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.